MRI-Based Radiomics Approach Predicts Tumor Recurrence in ER + /HER2 − Early Breast Cancer Patients

Oncotype Dx Recurrence Score (RS) has been validated in patients with ER + /HER2 − invasive breast carcinoma to estimate patient risk of recurrence and guide the use of adjuvant chemotherapy. We investigated the role of MRI-based radiomics features extracted from the tumor and the peritumoral tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiacchiaretta, Piero, Mastrodicasa, Domenico, Chiarelli, Antonio Maria, Luberti, Riccardo, Croce, Pierpaolo, Sguera, Mario, Torrione, Concetta, Marinelli, Camilla, Marchetti, Chiara, Domenico, Angelucci, Cocco, Giulio, Di Credico, Angela, Russo, Alessandro, D’Eramo, Claudia, Corvino, Antonio, Colasurdo, Marco, Sensi, Stefano L., Muzi, Marzia, Caulo, Massimo, Delli Pizzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287859/
https://www.ncbi.nlm.nih.gov/pubmed/36698037
http://dx.doi.org/10.1007/s10278-023-00781-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287859/
https://www.ncbi.nlm.nih.gov/pubmed/36698037
http://dx.doi.org/10.1007/s10278-023-00781-5

Ejemplares similares